Prevention and treatment of NSAID-induced gastroduodenal injury
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology
Link
http://link.springer.com/content/pdf/10.1007/s11938-006-0033-4.pdf
Reference61 articles.
1. Hawkey CJ: Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 2000, 119: 521–535.
2. Bombardier C, Laine L, Reicin A, et al.: Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR study group. N Engl J Med 2000, 343: 1520–1528. This study showed that treatment with rofecoxib, 50 mg/d, was associated with reduced incidence of serious upper GI events and increased incidence of myocardial infarction when compared with naproxen, 500 mg twice daily, taken for a mean of 9 months.
3. Silverstein FE, Faich G, Goldstein JL, et al.: Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study. JAMA 2000, 284: 1247–1255. When compared with NSAIDs, high-dose celecoxib (400 mg twice daily) was associated with reduced incidence of upper GI complications in patients not taking low-dose aspirin. No differences were observed in patients taking low-dose aspirin.
4. Schnitzer TJ, Burmester GR, Mysler E, et al.: Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet 2004, 364: 665–674. When compared with nonselective NSAIDs, lumiracoxib, 400 mg/d, was associated with reduced incidence of upper GI complications. The differences were present in patients not taking low-dose aspirin, but there were no statistical differences in patients taking low-dose aspirin.
5. Lanas A, Panes J, Pique JM: Clinical implications of COX-1 and/or COX-2 inhibition for the distal gastrointestinal tract. Curr Pharm Des 2003, 9: 2253–2266.
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Carvedilol safeguards against aspirin-induced gastric damage in rats;Human & Experimental Toxicology;2020-04-15
2. Prevalence of Gastrointestinal and Cardiovascular Risk in Patients with Degenerative Lumbar Spinal Disease;Clinics in Orthopedic Surgery;2020
3. Effects of melatonin on acetylsalicylic acid induced gastroduodenal and jejunal mucosal injury;Biotechnic & Histochemistry;2018-10-03
4. Gastroprotective effect of bezafibrate, a peroxisome proliferator activated receptor α agonist and its mechanism in a rat model of aspirin-induced gastric ulcer;Advances in Digestive Medicine;2016-06-14
5. A Validated HPLC-DAD Method for Simultaneous Determination of Etodolac and Pantoprazole in Rat Plasma;Journal of Chemistry;2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3